A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus-Reference-Cited by-同舟云学术

A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus

Published:2016-10-11 Issue:2 Volume:26 Page:240-248
ISSN:1055-9965
Container-title:Cancer Epidemiology Biomarkers & Prevention
language:en
Short-container-title:Cancer Epidemiol Biomarkers Prev

Author:

Critchley-Thorne Rebecca J.,Davison Jon M.,Prichard Jeffrey W.,Reese Lia M.,Zhang Yi,Repa Kathleen,Li Jinhong,Diehl David L.,Jhala Nirag C.,Ginsberg Gregory G.,DeMarshall Maureen,Foxwell Tyler,Jobe Blair A.,Zaidi Ali H.,Duits Lucas C.,Bergman Jacques J.G.H.M.,Rustgi Anil,Falk Gary W.

Funder

Pennsylvania Department of Health

NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Tissue Systems Pathology Test Objectively Risk-Stratifies Patients With Barrett’s Esophagus;Journal of Clinical Gastroenterology;2024-07-02

2. Narrowing the Discrepancy in Interobserver Variability With Barrett’s Esophagus With Low-Grade Dysplasia: Will Biomarkers or Risk Testing Help?;Foregut: The Journal of the American Foregut Society;2024-05-21

3. The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia;Gastroenterology;2023-11

4. Multiplex SERS-Lectin-Immunoassay for Esophageal Adenocarcinoma Screening;ACS Applied Nano Materials;2023-10-30

5. A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB;Clinical and Translational Gastroenterology;2023-09-28